A clinical example of bilateral prophylactic mastectomy in the presence of BRCA gene mutations
- 1 January 2021
- journal article
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 10 (3)
- https://doi.org/10.17116/onkolog20211003143
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Genetically associated breast cancer. Prevention and treatmentNauchno-prakticheskii zhurnal «Medicinskaia genetika», 2019
- Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast SurgeonsAnnals of Surgical Oncology, 2019
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersPublished by American Medical Association (AMA) ,2017
- Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2International Journal of Cancer, 2016
- Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testingEuropean Journal of Human Genetics, 2016
- Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation CarriersJournal of Clinical Oncology, 2016
- Gene-Panel Sequencing and the Prediction of Breast-Cancer RiskNew England Journal of Medicine, 2015
- Magnetic Resonance Imaging Improves Breast Screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-AnalysisJournal of Clinical Oncology, 2015
- Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisBMJ, 2014
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACEJNCI Journal of the National Cancer Institute, 2013